Vincristine Sulfate: The Microtubule-Concentrating on Chemotherapy Agent Revolutionizing Oncology | Supplier & Manufacturer
1. What is Vincristine?
Vincristine sulfate is a dimeric Catharanthus alkaloid derived from the Madagascar periwinkle (Catharanthus roseus). As a microtubule-disrupting agent, it binds with excessive affinity to β-tubulin on the vinca area, inhibiting microtubule polymerization and disrupting mitotic spindle meeting. This triggers metaphase arrest ug apoptosis in quickly dividing cells. Labeled as a WHO Important Medication, it is clinically indispensable for treating acute leukemias, lymphomas, and strong tumors via its potent antimitotic exercise.
2. Supply, Chemical Properties & Identifiers
-
Supply: Remoted from Catharanthus roseus leaves; semi-synthesized from precursors catharanthine and vindoline
-
Mga Kinaiya sa Kemikal:
-
Ngalan sa Kemikal: Methyl (2β,3β,4β,5α,12β,19α)-15-[(5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indol-9-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate sulfate
-
Molekular nga Pamaagi: C₄₆H₅₆N₄O₁₀·H₂SO₄
-
Molekular nga Timbang: 923.04 g/mol
-
Panagway: White to off-white hygroscopic powder
-
Solubility: Freely soluble in water (30 mg/mL), sparingly soluble in ethanol
-
Kalig-on: Gentle-sensitive; degrades above pH 5.5
-
-
Panguna nga mga Identifier:
-
CAS: 2068-78-2 (vincristine sulfate)
-
Gidaghanon sa EC (EINECS): 218-216-0
-
MF: C₄₆H₅₈N₄O₁₄S
-
MW: 923.04
-
3. Pharmaceutical-Grade Specs & Scientific Profile
-
Labing maayo nga Produkto: Requires >99.5% HPLC purity, <0.1% vinblastine (poisonous analog), and endotoxin-free (<0.25 EU/mg). Shaanxi Zhonghong achieves this via countercurrent chromatography ug lyophilization stabilization.
-
Therapeutic Purposes:
-
Oncology: First-line for ALL (induction remedy), Hodgkin/non-Hodgkin lymphoma, neuroblastoma, Wilm’s tumor
-
Mekanismo: Binds tubulin dimer (Kd=85 nM) → suppresses microtubule dynamics → mitotic disaster
-
(Observe: Nattokinase demonstrates fibrinolytic exercise; no medical proof helps nephroprotective advantages)
-
-
Dosis:
-
IV Administration Solely: 1.4-2.0 mg/m² weekly (max 2 mg/dose)
-
No oral bioavailability; by no means self-administer
-
-
Crucial Security Profile:
-
Neurotoxicity: Dose-limiting peripheral neuropathy (sensory > motor)
-
Hematologic: Delicate myelosuppression (in contrast to vinblastine)
-
Autonomic Results: Ileus, bladder atony, orthostatic hypotension
-
Extravasation Threat: Extreme tissue necrosis requiring central line
-
Contraindications: Charcot-Marie-Tooth illness, intrathecal administration (deadly)
-
4. Shaanxi Zhonghong: cGMP Vinca Alkaloid Specialist
Uban sa 28+ years in plant-derived oncology APIs, we produce EP/USP-compliant vincristine sulfate:
-
Scientific Infrastructure:
-
5 College Joint Labs (Tubulin binding analysis)
-
Patented Tech: CN202310XXXXXX (Vindoline stabilization)
-
-
Analytical Capabilities:
-
UPLC-MS/MS (purity/impurities)
-
600MHz NMR (structural affirmation)
-
ICP-MS (elemental impurities)
-
LAL Chromogenic (endotoxins)
-
-
World Distribution: API shipments to 80+ internasyonal nga mga lokasyon with cold-chain compliance
5. Pharmaceutical High quality Specs
Klase | Parameter | Espesipikasyon | Teknik |
---|---|---|---|
Mga pestisidyo | Mga chlorpyrifos | ≤0.01 mg/kg | GC-MS/MS |
Dimethoate | ≤0.02 mg/kg | LC-MS/MS | |
Bug-at nga Metal | Si Pb | ≤1.0 ppm | ICP-MS (USP <232>) |
Cd | ≤0.5 ppm | ICP-MS | |
Microbiology | TAMC | ≤10² CFU/g | USP <61> |
E. coli | Wala/10g | USP <62> | |
Crucial Attributes | Vincristine Sulfate | ≥99.5% | HPLC-PDA (USP <621>) |
Vinblastine | ≤0.1% | UPLC-MS | |
Sulod sa Tubig | ≤4.0% | Karl Fischer | |
Endotoxins | <0.25 EU/mg | LAL (USP <85>) |
6. cGMP Manufacturing Course of
-
Botanical Sourcing: C. roseus cultivated underneath GACP tips
-
Alkaloid Extraction: Ethanol/water gradient extraction (pH 4.0)
-
Precursor Isolation: Ion-exchange chromatography (vindoline)
-
Oxidative Coupling: Fe³⁺/H₂O₂-mediated dimerization
-
Sulfation: Response with SO₃-pyridine complicated
-
Crystallization: Managed polymorph formation (Type II crystals)
-
Lyophilization: -50°C freeze-drying underneath nitrogen environment
-
Steril nga Pagsala: 0.22 µm membrane filtration
7. Scientific & Analysis Purposes
-
Oncology Protocols:
-
R-CHOP (lymphoma)
-
VDCLP (pediatric ALL)
-
-
Drug Supply Methods:
-
Liposomal encapsulation (Marqibo®)
-
Peptide-drug conjugates (tumor-targeted supply)
-
-
Neuroscience Analysis:
-
Axonal transport research
-
Neurotoxicity modeling
-
8. cGMP Taas nga kalidad nga Management Protocol
Zhonghong’s 360° QC consists of:
-
Pag-ila: ¹³C NMR (C-18/C-19 carbonyl resonance at 175.2 ppm)
-
Kaputli: HPLC-ELSD quantifies vincristine (≥99.5%) and vinblastine (≤0.1%)
-
Efficiency: Tubulin polymerization assay (IC₅₀ 0.1-0.3 μM)
-
Security: Bacterial endotoxins (kinetic chromogenic LAL), sterility testing (USP <71>)
-
Kalig-on: 24-month shelf-life at 2-8°C (ICH Q1A validated)
9. Chilly-Chain Packaging & Logistics
-
Main Container: Sort I amber vials (nitrogen headspace)
-
Ikaduha nga Pagputos: Vacuum-sealed Alu-PET pouches with desiccant
-
Pagtipig: 2-8°C shielded from gentle
-
Paghatud: World cold-chain transport (2-8°C) by way of DHL Thermonet
10. Mechanism & Improvements
-
Molecular Motion:
-
Excessive-affinity binding to βIII-tubulin isotype
-
Suppresses microtubule dynamic instability by 95%
-
Induces Bim-mediated apoptosis
-
-
Zhonghong Improvements:
-
Enzymatic dimerization (yield ↑35%)
-
Cryogenic milling for particle dimension management
-
-
Mga utlanan sa pag-analisa:
-
Tubulin isotype-specific analogs
-
Neuroprotective co-administration (glutamate antagonists)
-
-
Mga hagit:
-
Neurotoxicity administration
-
ABC transporter-mediated resistance
-
11. FAQ
Q1: Can vincristine be used as a dietary complement?
A: Completely not. Vincristine is a cytotoxic chemotherapy agent requiring medical supervision. Unauthorized use causes extreme neurotoxicity.
Q2: Does nattokinase profit kidney sufferers?
*A: No medical proof helps nattokinase for kidney illness. Vincristine requires dose adjustment in renal impairment (CrCl <30 mL/min).*
Q3: Why is vinblastine impurity managed?
*A: Vinblastine causes distinct myelotoxicity. Our UPLC-MS detects ≤0.05% impurity (ICH Q3A limits).*
This autumn: What distinguishes Zhonghong’s vincristine?
*A: cGMP manufacturing, ≥99.5% purity, endotoxin management (<0.25 EU/mg), and patented lyophilization expertise.*
Q5: Do you provide vincristine for ADCs?
*A: Sure. GMP-grade maleimide-activated vincristine accessible for antibody-drug conjugates (DAR 4-8).*
12. World Procurement
Supply cGMP vincristine sulfate:
✉️ E-mail: liaodaohai@gmail.com
🌐 Net: www.aiherba.com
Request: COA, DMF, regulatory help, and customized synthesis choices.
13. Panapos
Vincristine sulfate stays a cornerstone of pediatric and hematologic oncology with distinctive microtubule-targeting properties. Its medical utility is dependent upon ultra-taas nga kaputli (>99.5%), stringent neurotoxic impurity management, ug temperature-managed distribution. Shaanxi Zhonghong combines three many years of vinca alkaloid experience, patente nga kahanas sa stabilization, ug pagsunod sa cGMP to ship APIs assembly international pharmacopeial requirements. Associate with us for uncompromising high quality in most cancers therapeutics.
14. Mga pakisayran
-
Noble RL, et al. (1958). J Am Chem Soc. 80:3487. [DOI:10.1021/ja01546a092]
-
Jordan MA, et al. (1985). J Biol Chem. 260:14608. [PMID:2995464]
-
WHO EML (2023): Vincristine sulfate injection
-
USP Monograph: Vincristine Sulfate. USP44-NF39
-
EMA Guideline CPMP/QWP/1850/04
-
Lobert S, et al. (1996). Biochemistry. 35:6806. [DOI:10.1021/bi952483n]
-
Zhonghong Patent: CN202310XXXXXX (Cryo-milling course of)
-
ICH Q3D (R2): Elemental Impurities
-
FDA Label: Vincristine Sulfate Injection
-
Gidding CEM, et al. (1999). Most cancers Chemother Pharmacol. 44:266. [DOI:10.1007/s002800050976]
评价
目前还没有评价